NRF2 is reportedly deregulated in adipose tissue during obesity, and this transcriptional factor modulates the progression of atherosclerosis, inflammation and lipid homeostasis, including other cardiovascular risk factors associated with obesity. The gene discussed is NFE2L2; the disease is atherosclerosis.